Intention-to-treat. What is the question?

Area of Science:

• Biostatistics
• Clinical Epidemiology
• Medical Research Methodology

Background:

• Randomized Controlled Trials (RCTs) are commonly analyzed using Intention-to-Treat (ITT) principles, including all subject data irrespective of protocol adherence.
• While ITT can offer insights, it often fails to directly address the primary research question of differential treatment efficacy.

Discussion:

• ITT analysis merges the questions of intervention effectiveness and implementation compliance, potentially leading to misuse and misinterpretation.
• Examples involving vitamin E for cardiovascular risk and dietary interventions illustrate how ITT can inaccurately portray treatment outcomes and merit.
• The misuse of ITT is not a statistical anomaly but a significant issue with implications for scientific integrity and public health guidance.

Key Insights:

• ITT analysis may accurately reflect outcomes under recommended treatments but is unsuitable when separate adherence and performance data are available.
• The conflation of efficacy and compliance in ITT can lead to treatments with proven benefits being dismissed or diets with differing outcomes being presented as equivalent.
• Accurate reporting of RCT results should focus on the specific questions answered by the analysis, rather than solely on the analytical method used.

Outlook:

• Future research should explore alternative analytical frameworks that clearly distinguish between treatment efficacy and patient adherence.
• Developing standardized reporting guidelines that emphasize the specific questions addressed by analyses is crucial for improving the interpretability of RCTs.
• Promoting a clearer understanding of analytical limitations among researchers and healthcare professionals will enhance the reliable application of evidence-based medicine.